[1]
M. M.Y. Awad and A. M. Younis, “Empagliflozin alleviates diabetic nephropathy in albino rats through its antioxidative and anti-inflammatory action”, JJOAS-N, vol. 17, no. 1, pp. 33-37, Jun. 2023.